Women with ovarian cancer are more likely to survive the often-fatal disease if their doctors follow recommended treatment guidelines set by the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers that develops guidelines for most cancers.
But a UC Irvine study of more than 13, 321 ovarian cancer patients in California found nearly 60 percent didn’t receive such treatment, which usually involves a combination of surgery and chemotherapy.
The study, released today at the annual Society of Gynecological Oncology meeting in Los Angeles, found that doctors who treat ten or more women with ovarian cancer each year and hospitals that treat 20 or more ovarian cancer patients, were more likely than others to provide the recommended treatment.
Moreover, the study found those patients who received the recommended treatment were 30 percent less likely to die of the disease.
But researcher found that even the so-called “high-volume” surgeons, who treated the most ovarian cancer cases, only offered the guideline care to their patients about half the time.
The study’s authors suggest women with the disease should seek care from providers who treat larger numbers of ovarian cancer cases and who follow the guidelines recommended by the NCCN.
Ovarian cancer kills 15,000 women in the U-S each year.